by Jordana Choucair | Apr 26, 2022 | Life Sciences
The Food and Drug Administration (FDA) on Monday gave its first full approval for a COVID-19 treatment for children under 12. The agency granted approval to the treatment remdesivir, also known as Veklury, made by Gilead Sciences, which has already been approved as a...
by Jordana Choucair | Apr 26, 2022 | Payers
Blue Cross Blue Shield of Michigan (BCBSM) and Honest Medical Group announced they are launching a joint venture that aims to make it easier for providers to transition to value-based care for Medicare patients. The venture aligns with BCBSM’s continued expansion of...
by Jordana Choucair | Apr 26, 2022 | Providers
The American Hospital Association (AHA) released its pandemic hospital costs report, highlighting an 11 percent overall increase—as well as a 20 percent per-patient increase—in total hospital expenses from 2019 through the end of 2021. The report found that, over the...
by Jordana Choucair | Apr 26, 2022 | Providers
Centers for Medicare &Medicaid Services Administrator Chiquita Brooks-LaSure defended the agency’s planned 3.2 percent payment increase for hospitals. Brooks-LaSure said that officials want to reward facilities that are “moving to whole-person patient...
by Jordana Choucair | Apr 25, 2022 | D.C. News
Congress returns this week with additional COVID-19 response funding at the top of lawmakers’ to-do list. However, a separate fight over a pandemic-era immigration policy could slow efforts to pass the $10 billion pandemic relief bill. Republicans are trying to...
Recent Comments